You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, SARS (Severe Acute Respiratory Syndrome) Trial (Hydroxychloroquine, Vitamins and Minerals, Azithromycin)

Withdrawn
  • Covid19
  • SARS (Severe Acute Respiratory Syndrome)
  • (no location specified)
Dec 5, 2021

COVID-19 Trial in New York (Hydroxychloroquine (HCQ))

Completed
Has Results
  • COVID-19
  • Hydroxychloroquine (HCQ)
  • New York, New York
    NYU Langone Health
Dec 12, 2022

COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))

Active, not recruiting
  • COVID-19 Vaccine
  • ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
  • Ciudad Autónoma de Buenos Aires, Argentina
    Unidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022

Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Trial in United States (Varespladib,

Terminated
  • Coronavirus Disease 2019
  • Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
  • Ventura, California
  • +6 more
Dec 14, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)

Recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • SARS-Cov-2 infection
  • Ferrara, Italy
    Azienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022

Severe Exacerbation of Severe Acute Respiratory Syndrome

Active, not recruiting
  • SARS-CoV-2
    • Tokyo, Japan
      CMIC Co. Ltd.,
    Jun 5, 2023

    Japan After Severe Acute Respiratory Syndrome Coronavirus 2

    Not yet recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co., Ltd
      Jun 6, 2023

      How Future Surgery Will Benefit From Severe Acute Respiratory

      Completed
      • COVID-19
      • Health Behavior
      • COVID-surg-SPIGC questionnaire
      • Roma, Rome, Italy
      • +2 more
      Nov 17, 2022

      Assess Infection Rate of Severe Acute Respiratory Syndrome -

      Completed
      • Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
        • Chicago, Illinois
          Great Lakes Clinical Trials /ID# 224874
        Oct 6, 2022

        COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

        Not yet recruiting
        • COVID-19 Infection
        • COVID-19 Vaccine Adverse Reaction
        • LEM-mR203
        • Placebo
        • Seoul, Korea, Republic of
          Seoul National University Hospital Clinical Trials Center
        Sep 12, 2023

        Japan of Shock and Anaphylaxis After Severe Acute Respiratory

        Active, not recruiting
        • SARS-CoV-2
          • Tokyo, Japan
            CMIC Co., Ltd.
          Jun 5, 2023

          Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)

          Enrolling by invitation
          • Covid19
          • +2 more
          • Inspiratory muscle trainer
          • diaphragmatic release
          • Giza, Dokki, Egypt
            Faculty of Physical Therapy
          Jun 17, 2022

          Non-invasive Respiratory Support on Outcome and Its Risks in

          Active, not recruiting
          • COVID-19
          • Hypoxemic Respiratory Failure
          • High flow nasal oxygen (HFNO, more than 15 L/min)
          • Rotterdam, Zuid-Holland, Netherlands
            Erasmus MC
          Sep 4, 2023

          Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)

          Completed
          • Covid19
          • anti-SARS-CoV-2 IgY
          • Placebo
          • Nedlands, Western Australia, Australia
            Linear Clinical Research - Harry Perkins Research Institute
          Jun 30, 2022

          Long-term Sequelae of Coronavirus Disease 2019 Pneumonia With

          Active, not recruiting
          • COVID-19 Pneumonia
          • +4 more
            • Faro, Portugal
            • +1 more
            Apr 26, 2023

            COVID-19 Biological Samples Collection

            Recruiting
            • Infection Viral
            • biological samples collection
            • Bordeaux, France
              Centre Hospitalier Universitaire de Bordeaux
            Dec 7, 2022

            Antigen Rapid Diagnostic Tests for Community Identification of

            Recruiting
            • Severe Acute Respiratory Syndrome Coronavirus 2 Infection
            • Rapid Antigen Testing
            • Kiambu, Kenya
              Kiambu County
            Jul 12, 2022

            COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium

            Terminated
            Has Results
            • COVID-19
            • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
            • C19-IG 20%
            • 0.9% Sodium chloride
            • L'Hospitalet de Llobregat, Barcelona, Spain
            • +11 more
            Nov 8, 2022

            a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul

            Completed
            • a Randomized Double-blind Study
            • +2 more
            • Sahloul, Sousse, Tunisia
              Riadh Boukef
            Jan 2, 2023

            EuGeni Rapid Antigen Test for Qualitative Detection of Severe

            Terminated
            • SARS-CoV-2 Infection
            • EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
            • Split, Croatia
            • +4 more
            Jan 3, 2023

            Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial (MBS-COV, Placebo)

            Not yet recruiting
            • Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
            • (no location specified)
            Jul 11, 2023

            COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and

            Active, not recruiting
            • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
            • +2 more
            • SARS-CoV-2 and/or MIS-C Exposure
            • Loma Linda, California
            • +19 more
            Sep 22, 2022

            2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial (Famotidine, Celecoxib, Placebo)

            Not yet recruiting
            • 2019 Novel Coronavirus Disease
            • +11 more
            • (no location specified)
            Aug 15, 2022

            Post-COVID-19 Syndrome Trial in Istanbul (non-invasive auricular vagus stimulation, Placebo Non Invasive Vagus Stimulation)

            Recruiting
            • Post-COVID-19 Syndrome
            • non-invasive auricular vagus stimulation
            • Placebo Non Invasive Vagus Stimulation
            • Istanbul, Istanbul Avrupa Kitasi, Turkey
              Bahçeşehir University
            Mar 10, 2023

            Coronavirus Infection, Severe Acute Respiratory Syndrome Trial in Wolverhampton (Survey, SARS-CoV-2 antibody test)

            Active, not recruiting
            • Coronavirus Infection
            • Severe Acute Respiratory Syndrome
            • Survey
            • SARS-CoV-2 antibody test
            • Wolverhampton, United Kingdom
              The Royal Wolverhampton NHS Trust
            Aug 15, 2022